Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
An Ames test was performed to investigate the potential of Bayscript Black TP LXS 51134 to induce gene mutations according to the plate incorporation test (experiment I) and the pre-incubation test (experiment II and IIa) using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and the Escherichia coli strain WP2 uvrA, following OECD TG 471.
Because the test item is an azo-dye, a special test design according to Prival and Mitchell (1982) was applied as proposed in OECD TG 471. The assay was performed in three independent experiments. Experiment I was performed with induced rat liver S9 mix as an exogenous metabolic activation system and experiment II and IIa were performed with non-induced hamster liver S9 mix.
During the mutagenicity test and under the experimental conditions reported (OECD TG 471, modified version for azo-dyes), the test item did induce gene mutations by frameshifts in the genome of the strain TA 98 in the presence of non-induced hamster liver S9 mix.
Therefore, Bayscript Black TP LXS 51134 is considered to be mutagenic in this Salmonella typhimurium and Escherichia coli reverse mutation assay.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2020
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- other: The Japanese Ministry of Economy Trade and Industry (METI), Ministry of Health, Labour and Welfare (MHLW) and Ministry of the Environment (MOE) Guidelines of 31 March 2011
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Principles of method if other than guideline:
- Modification according to Prival and Mitchell (1982) (as proposed in OECD TG 471 for azo dyes):
Prival. M.J. and V.D. Mitchell (1982) Analysis of a method for testing azo dyes for mutagenic activity in Salmonella typhimurium in the presence of flavin mononucleotide and hamster liver S9 Mutation Res. 97, 103-116 - GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat S9 mix:from phenobarbital/beta-naphthoflavone incuded rats, prepared by ICCR-Rossdorf GmbH
hamster S9 mix: from uninduced Syrian golden hamsters, prepared by ICCR-Rossdorf GmbH - Test concentrations with justification for top dose:
- 10; 33; 100; 333; 1000; 2500; and 5000 μg/plate.
In the pre-experiment the concentration range of the test item was 3 – 5000 μg/plate. - Vehicle / solvent:
- On the day of the experiment, the test item was dissolved in deionized water. The solvent was chosen because of its solubility properties and its relative nontoxicity to the bacteria.
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Remarks:
- for cultures with hamster S9 mix
- Positive control substance:
- congo red
- other: 2-aminoanthacene
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Remarks:
- for cultures with rat S9 mix
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 4-nitro-o-phenylene-diamine, 4-NOPD; 2-aminoanthracene, 2-AA
- Details on test system and experimental conditions:
- The experiments were performed to assess the potential of the test item to induce gene mutations by means of two independent Salmonella typhimurium and Escherichia coli reverse mutation assays. Because the test item is an azo-dye, a special test design according to Prival and Mitchell (1982) was applied as proposed in OECD TG 471.
Experiment I was performed as a plate incorporation assay with induced rat liver S9 mix as an exogenous metabolic activation system. Since a negative was obtained in this experiment, experiment II was performed as a pre-incubation assay with non-induced hamster liver S9 mix. In experiment II a single positive effect was observed in strain TA 98 in the presence of S9 mix. To validate this effect this part of experiment II was repeated as a pre-incubation assay with adequately spaced concentrations. Since the data of the solvent and negative control of strain TA 100 in the presence of S9 mix were invalid, this part of experiment II repeated. The repeated parts are reported as experiment IIa.
Each concentration, including the controls, was tested in triplicate. The test item was tested as solution in water at the following concentrations in both experiments:
10; 33; 100; 333; 1000; 2500; and 5000 μg/plate - Rationale for test conditions:
- In the pre-experiment the concentration range of the test item was 3 – 5000 μg/plate. The pre-experiment is reported as experiment I. Based on the minor toxic effects and the desnse coloring of the overlay agar on the incubated agar, observed in experiment I, seven concentrations were tested in experiment II. 5000 μg/plate were chosen as maximal concentration in experiment II.
The concentration range included two logarithmic decades. The following concentrations were tested in experiment II:
10; 33; 100; 333; 1000; 2500; and 5000 μg/plate
To validate a single positive effect observed in experiment II in strain TA 98 in the presence of S9 mix this part of experiment II was repeated as a pre-incubation assay with adequately spaced concentrations. Furthermore the data of the solvent and negative control of strain TA 100 in the presence of S9 mix were invalid and therefore repeated (reported as experiment IIa). The following concentrations were tested in experiment IIa:
Strain TA 98 (with S9 mix): 33; 100; 200; 400; 800; 1600, and 3200 μg/plate
Strain TA 100 (with S9 mix): 10; 33; 100; 333; 1000; 2500; and 5000 μg/plate - Evaluation criteria:
- A test item is considered as a mutagen if a biologically relevant increase in the number of revertants of twofold or above (strains TA 98, TA 100, and WP2 uvrA) or threefold or above (strains TA 1535 and TA 1537) the spontaneous mutation rate of the corresponding solvent control is observed.
A dose dependent increase is considered biologically relevant if the threshold is reached or exceeded at more than one concentration.
An increase of revertant colonies equal or above the threshold at only one concentration is judged as biologically relevant if reproduced in an independent second experiment.
A dose dependent increase in the number of revertant colonies below the threshold is regarded as an indication of a mutagenic potential if reproduced in an independent second experiment. However, whenever the colony counts remain within the historical range of negative and solvent controls such an increase is not considered biologically relevant. - Statistics:
- According to the OECD guideline 471, a statistical analysis of the data is not mandatory.
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Remarks:
- in the presence of hamster liver S9 mix
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- other: Salmonella typhimurium strains TA 1535, TA 1537, TA 100, and the Escherichia coli strain WP2 uvrA
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- in the presence and absence of hamster liver S9 mix
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- other: Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and the Escherichia coli strain WP2 uvrA
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- in the presence and absence of rat liver S9 mix
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- In experiment II a substantial and dose depended increase in revertant colony numbers was observed following treatment with Bayscript Black TP LXS 51134 in strain TA 98 in the presence of non-induced hamster liver S9 mix. The threshold of twice the number of the corresponding solvent control was exceeded at 333 μg/plate solely. To validate this positive effect and to proof its reproducibility strain TA 98 with S9 mix was repeated as a pre-incubation assay with adequately spaced concentrations. In the repeated experiment again an increase in revertant colony number was observed. The threshold of twice the number in revertant colony count of the corresponding solvent control was exceeded from 100 to 800 μg/plate. At the next higher concentrations the number in revertant colony count decreased below the significant threshold of twice the number of the corresponding solvent control.
- Conclusions:
- Bayscript Black TP LXS 51134 is considered to be mutagenic in this bacterial reverse mutation assay (frameshift mutations in the genome of strain TA 98 in the presence of non-induced hamster liver S9 mix).
- Executive summary:
This study was performed to investigate the potential of Bayscript Black TP LXS 51134 to induce gene mutations according to the plate incorporation test (experiment I) and the pre-incubation test (experiment II and IIa) using the Salmonella typhimurium strains TA 1535, TA 1537, TA 98, TA 100, and the Escherichia coli strain WP2 uvrA, following OECD TG 471.
Because the test item is an azo-dye, a special test design according to Prival and Mitchell (1982) was applied as proposed in OECD TG 471. The assay was performed in three independent experiments. Experiment I was performed with induced rat liver S9 mix as an exogenous metabolic activation system and experiment II and IIa were performed with non-induced hamster liver S9 mix.During the mutagenicity test and under the experimental conditions reported (OECD TG 471, modified version for azo-dyes), the test item did induce gene mutations by frameshifts in the genome of the strain TA 98 in the presence of non-induced hamster liver S9 mix.
Therefore, Bayscript Black TP LXS 51134 is considered to be mutagenic in this Salmonella typhimurium and Escherichia coli reverse mutation assay.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Genetic toxicity in vivo
Description of key information
Due to the positive results of the Ames test according to OECD Guideline 471 (Bacterial Reverse Mutation Assay Test) the conduction of an in-vivo Comet assay is proposed to evaluate potential mutagenic activity in vivo.
Additional information
Justification for classification or non-classification
To assess the relevance of the positive outcome of an bacterial mutagenesis test (Ames Test) for the in vivo situation an in vivo Comet-assay is proposed. As long as the results of this test are not available, the registered substance is considered as 'inconclusive' with regard to mutagenicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.